George O. Negrea, Rebecca Elstrom, Steven L. Allen, Kanti R. Rai, Rashid M. Abbasi, Charles M. Farber, Nick Teoh, Heather Horne, William A. Wegener, David M. Goldenberg. Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin’s lymphoma. Haematologica 2011;96(4):567-573; https://doi.org/10.3324/haematol.2010.037390.